Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies

Cell-based cancer immunotherapy has revolutionized the treatment of hematological malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell therapies have received approvals for treating leukemias, lymphomas, and multiple myeloma following unprecedented clinical resp...

詳細記述

書誌詳細

出版年:	Cells
主要な著者:	Yan-Ruide Li, Zachary Spencer Dunn, Yang Zhou, Derek Lee, Lili Yang
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2021-12-01
主題:	stem cell engineering allogeneic cancer therapy off-the-shelf cell therapy chimeric antigen receptor (CAR) T cell receptor (TCR) graft-versus-host disease (GvHD)
オンライン･アクセス:	https://www.mdpi.com/2073-4409/10/12/3497